Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

4 Pharma Stocks That Could Be Losers With the $1.9 Trillion Stimulus Package
Motley Fool
Wed, 03/17/21 - 10:39 am
Tags:
stimulus, pharma stocks, Eli Lilly, Merck, Jazz Pharmaceuticals, AbbVie
AbbVie looks to shed Allergan's legacy women's health unit as it hunkers down for Humira biosim doomsday — report
Endpoints
Tue, 03/16/21 - 11:04 am
Tags:
AbbVie, Women's Health, Allergan, Humira, M&A
AbbVie to Fund Mitokinin's Parkinson Research with Option to Buy
BioSpace
Tue, 03/2/21 - 11:55 pm
Tags:
AbbVie, Parkinson's Disease, Mitokinin
AbbVie sells biologics plant to Pharmaron, fueling the China company's cell and gene therapy ambitions
Fierce Pharma
Tue, 03/2/21 - 11:52 pm
Tags:
AbbVie, UK, biologics, drug manufacturing, Pharmaron
AbbVie puts an end to Botox trade secrets suit, imposes royalty, license deal on competitor Evolus
Endpoints
Fri, 02/19/21 - 10:43 am
Tags:
AbbVie, Botox, trade secrets, Evolus
AbbVie adds to the Botox war chest with a 12th FDA approval — but competition is fast approaching
Endpoints
Wed, 02/10/21 - 10:39 pm
Tags:
AbbVie, Botox, bladder muscle overactivity
After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact
Fierce Biotech
Wed, 02/10/21 - 10:27 am
Tags:
AbbVie, Editas Medicine, CRISPR, Caribou Biosciences, gene editing
AbbVie's immunology newbies Skyrizi and Rinvoq pick up the slack from declining Humira, but safety questions dog execs
Fierce Pharma
Wed, 02/3/21 - 11:22 pm
Tags:
AbbVie, FDA, Skyrizi, Rinvoq, Humira, earnings
AZ says Calquence is a safer drug than Imbruvica
Pharmaforum
Mon, 01/25/21 - 11:02 am
Tags:
AstraZeneca, Calquence, Imbruvica, JNJ, AbbVie, CLL
Pharma TV ad spenders blow up December with spendiest month of 2020
Fierce Pharma
Wed, 01/6/21 - 10:50 am
Tags:
television ads, AbbVie, Humira, Novo Nordisk, DTC ads
AbbVie eyes Humira matching move into psoriatic arthritis for immunology follow-up Skyrizi
Endpoints
Tue, 01/5/21 - 11:02 pm
Tags:
AbbVie, Humira, psoriatic arthritis, Skyrizi
AbbVie dumps unwanted Sosei neuro pact from Allergan's past
Fierce Biotech
Tue, 01/5/21 - 10:17 am
Tags:
AbbVie, Allergan, M&A, Sosei
Pfizer, AbbVie, BMS, Teva, Sanofi, Gilead and others ring in 2021 with nearly 600 price hikes
Fierce Pharma
Mon, 01/4/21 - 11:04 pm
Tags:
drug pricing, Pfizer, AbbVie, Teva Pharmaceutical, Sanofi, Gilead Sciences
Aji Bio-Pharma and Revance in manufacturing deal for anti-wrinkle rival to Botox
Biopharma Reporter
Tue, 12/22/20 - 10:51 am
Tags:
Aji Biopharma, ReVance, drug manufacturing, aesthetics, daxiabotulinumtoxinA, Botox, Allergan, AbbVie
AbbVie's Botox wins reprieve as agency bars Evolus' Jeaveau for alleged trade-secrets theft
Fierce Pharma
Thu, 12/17/20 - 06:26 pm
Tags:
AbbVie, Allergan, Botox, ITC, Evolus, Jeuveau
AbbVie's Covid-19 antibody partner wraps $221M Hong Kong IPO
Endpoints
Thu, 12/17/20 - 11:05 am
Tags:
AbbVie, Harbour BioMed, IPOs, Hong Kong
AbbVie pulls the trigger on a Covid-19 antibody, going all in on a drug discovered by research alliance
Endpoints
Mon, 12/14/20 - 11:04 pm
Tags:
AbbVie, COVID-19, antibodies
AbbVie's Hopes of Replacing Humira Sales with Rinvoq Gains Momentum for Ulcerative Colitis
BioSpace
Wed, 12/9/20 - 11:21 pm
Tags:
AbbVie, Rinvoq, ulcerative colitis, clinical trials
AbbVie chases its next golden goose for a post-Humira future with new ulcerative colitis data for Rinvoq
Endpoints
Wed, 12/9/20 - 10:39 am
Tags:
AbbVie, Allergan, Humira, Rinvoq
ASH: AstraZeneca's Calquence, BeiGene's Brukinsa turn heads with new data, putting Imbruvica on notice
Fierce Pharma
Sun, 12/6/20 - 07:15 pm
Tags:
AstraZeneca, BeiGene, JNJ, AbbVie, Calquence, Brukinsa, Imbruvica, CLL, ASH2020

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.